1-2 of 2
Anne Lewin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families

Available to Purchase
Tai W. Wong, Francis Y. Lee, Stuart Emanuel, Craig Fairchild, Joseph Fargnoli, Brian Fink, Ashvinikumar Gavai, Amy Hammell, Benjamin Henley, Christine Hilt, John T. Hunt, Bala Krishnan, Daniel Kukral, Anne Lewin, Harold Malone, Derek Norris, Simone Oppenheimer, Gregory Vite, Chiang Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4031–4041.
https://doi.org/10.1158/1078-0432.CCR-10-3417
Published: 15 June 2011
View articletitled, Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families
Open the PDF for Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families in another window
Includes: Supplementary data
Journal Articles

Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models

Available to Purchase
Francis Y.F. Lee, Kelly L. Covello, Stephen Castaneda, Donald R. Hawken, David Kan, Anne Lewin, Mei-Li Wen, Rolf-Peter Ryseck, Craig R. Fairchild, Joseph Fargnoli, Robert Kramer
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (24): 8123–8131.
https://doi.org/10.1158/1078-0432.CCR-08-0025
Published: 15 December 2008
View articletitled, Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models
Open the PDF for Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models in another window